National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 619836

History of Changes from the VAERS Wayback Machine

First Appeared on 5/14/2017

VAERS ID: 619836
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. K021266 / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Vision blurred, Visual acuity reduced

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Prophylaxis; Immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1512IRL010602

Write-up:Information has been received from Sanofi Pasteur MSD (reference # IE-1577272925-2015001093) on 18-DEC-2015. This case was received from the health authority on 16-Dec-2015. Ref IE-HPRA-2015-025259. The case was assessed as serious due to disability and medical important condition. Initial report was received by the RA on 17/Nov/2015 from a member of the public (patient''s mother) which concerns a 12 year old Female patient who experienced Visual acuity reduced and Vision blurred following vaccination with HPV vaccine (brand unspecified) and DTaP vaccine (brand unspecified). Concomitant medications: None. Medical history/concurrent conditions: None reported. The patient was vaccinated with both HPV vaccine and DTaP vaccine on 22/Sep/2015. A few days after the vaccine, the patient''s eye sight immediately declined and her vision became blurred really quickly and the patient was unable to see as she had done before the vaccines. The reporter indicated that the patient''s glasses no longer work for her and she can no longer see the black board in school or make out faces as she could before the vaccine. The reporter indicated that the patient had 30% vision since she was born. The patient attended hospital and was stable and recently discharged as her condition would not change. Corrective treatment: None. At the time of reporting the patient''s symptoms were persisting. Additional information was received by the RA from a Community Care Doctor on 01/Dec/2015: The reporter confirmed the brand name GARDASIL and BOOSTRIX), dose, route of administration, batch number and date of administration of both vaccines. The reporter stated that the patient''s mother recounts her daughter''s vision has deteriorated since these vaccinations and has been ongoing for the past 10 weeks. The patient has been referred onto an optician and a paediatric hospital for further review.

New Search

Link To This Search Result:

Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166